The global catecholamines market, a critical segment of the pharmaceutical industry, has been growing significantly. Valued at US$ 4.0 billion in 2022, the market is projected to expand at a CAGR of 5.9% from 2023 to 2031, reaching more than US$ 6.7 billion by 2031. This growth is driven by increasing cardiovascular disease incidence, technological advancements in drug delivery systems, and an...